All Episodes
The Lancet Respiratory Medicine in conversation with — 62 episodes
Anne-Marie Dingemans; Isabelle Opiz; Corinne Faivre-Finn on a consensus definition of stage III Non-Small Cell Lung Cancer technical resectability
Anne Holland and Christine McDonald
Marion Moseby-Knappe on Blood biomarkers for the prediction of outcome after cardiac arrest
Sailesh Kotecha on Prematurity-associated lung disease
Neil Greening and Hnin Aung on Multidimensional prognostic risk stratification of COPD exacerbations
Finn McQuaid and Matthew Saunders on Tuberculosis and Climate change
Toby Maher on ENV-101 in patients with idiopathic pulmonary fibrosis
Guy Brusselle and Celeste Porsbjerg on State-of-the-art insights into prevention, development, and management of asthma
Joan Soriano on Global Epidemiology of Respiratory Disease
Carole Mitnick & Lorenzo Guglielmetti on the ENDTB-Q trial
Lorenzo Guglielmetti parla del trial clinico ENDTB-Q (in Italian)
Laura Garriga-Grimau on bronchiectasis in children and young people
Marcus J Schultz and Prashant Nasa on defining and subphenotyping ARDS
Hjalmar Bouma on sepsis in patients who are immunocompromised
Simon Wolf on pulmonary embolism in children and adolescents in the US during 2016 and 2019
Sandeep Sahay and Franck Rahaghi on future treatment paradigms in pulmonary arterial hypertension
Sergio Harari sul trattamento della linfangioleiomiomatosi (LAM) (in Italian)
Sergio Harari on the treatment of lymphangioleiomyomatosis (LAM)
Robert Kullberg on empirical antibiotics for Sepsis
Heather Zar on early-life RSV disease and long-term respiratory health
Margaux Mesle on lives saved by COVID-19 vaccination
James Hull on protecting the respiratory health of athletes
Eric Lim on treatments for pleural mesothelioma
Anne Chang on the burden of chronic respiratory diseases in Indigenous people
Daniel Steinfort and Shankar Siva on radiotherapy field planning in patients with NSCLC
Daniel Prieto-Alhambra, Annika Jödicke, and Martí Català on vaccination to prevent Long COVID
Sarah Gorst and Tim Nicholson on long COVID outcomes
Betty Raman on multiorgan MRI abnormalities after hospitalisation with COVID-19
Keith Chappell on a bivalent recombinant vaccine for COVID-19
James Chalmers on bronchiectasis across Europe
Richard Costello on management of uncontrolled asthma
Keiju Aokage on segmentectomy for ground-glass-dominant lung cancer
Carol Hodgson on post-discharge outcomes for ECMO patients
Emma Grainger on 10 years of The Lancet Respiratory Medicine
Vivienne Kahlmann and Catharina Moor on the TIRED study
Yves Lacasse on long-term oxygen therapy for COPD
Rachael Evans on living with long COVID
Daniel Munblit and Dale Needham on core outcomes post-COVID-19
Daiana Stolz on antibiotic stewardship in pneumonia
Ablo Wachinou on sleep disordered breathing in Benin
Peter Openshaw and Felicity Liew on corticosteroids in the early in the treatment of COVID
Dinh Bui on preterm birth and lung function deficits
Ruvim Izĭckson on a joint flu and COVID-19 vaccine
Wisia Wedzicha on a vaccine for COPD
Eileen Rubin on patient-centered ARDS
Daniel Altmann on COVID boosters
Michael Kreuter on interstitial lung disease
Bairbre McNicholas and Jie Li on awake prone positioning and COVID-19
Charles Sprung and authors on end-of-life practices in ICUs globally
Christopher Brightling on tezepelumab in patients with moderate-to-severe uncontrolled asthma
Paul Verweij on COVID-19 associated aspergillosis
Ignacio Rubio on COVID-19 pathophysiology and phenotypes
Kiran Shekar on cytokine adsorption and severe COVID-19 pneumonia
Fan Chung on chronic cough and long COVID
Mepolizumab and the treatment of chronic rhinosinusitis
Inhaled budesonide in the treatment of early COVID-19
Tocilizumab and COVID-19
Interferon treatment and COVID-19
Evaluating deterioration in patients with acute COVID-19
Treatment options in patients with systemic sclerosis-associated interstitial lung disease
COVID-19 and severe influenza
The second wave and homeless populations